Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 02, 2024

Trastuzumab Deruxtecan for HER2-Positive Breast Cancer Brain Metastases



Additional Info

Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis
ESMO Open 2024 Feb 05;9(2)102233, I Michelon, M Vilbert, AD Marinho, CER Castro, MI Dacoregio, C Stecca, LR Soares, MV Batista, S Braga, A Saeed, L Cavalcante

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading